NanoEnTek (039860.KQ) Stock Price

NanoEnTek Price

🇰🇷CLOSED
0 KRW
Market closed
Today +/-
Today %

NanoEnTek (039860.KQ) Stock | ISIN KR7039860002. NanoEnTek operates in the Health sector.

NanoEnTek stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of NanoEnTek over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how NanoEnTek stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing NanoEnTek's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

NanoEnTek Stock Price History
DateNanoEnTek Price
Access this data via the Eulerpool API

NanoEnTek Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
23.98 B KRW
-4.37 B KRW
-14.3 B KRW
Jan 1, 2006
10.98 B KRW
-5.18 B KRW
-19.33 B KRW
Jan 1, 2007
11.12 B KRW
-5.17 B KRW
-17.6 B KRW
Jan 1, 2008
6.44 B KRW
-1.61 B KRW
-5.47 B KRW
Jan 1, 2009
13.27 B KRW
1.78 B KRW
14.28 B KRW
Jan 1, 2010
15.16 B KRW
-1.96 B KRW
-6.59 B KRW
Jan 1, 2011
13.15 B KRW
-7.98 B KRW
-12.2 B KRW
Jan 1, 2012
13.44 B KRW
-5.33 B KRW
-5.88 B KRW
Jan 1, 2013
19.08 B KRW
-473 M KRW
-1.24 B KRW
Jan 1, 2014
19.5 B KRW
-2.59 B KRW
-2.46 B KRW
Jan 1, 2015
24.84 B KRW
-7.21 B KRW
-7.28 B KRW
Jan 1, 2016
22.21 B KRW
-9.69 B KRW
-14.8 B KRW
Jan 1, 2017
23.81 B KRW
1.67 B KRW
-2.07 B KRW
Jan 1, 2018
25.8 B KRW
2.83 B KRW
3.31 B KRW
Jan 1, 2019
26.26 B KRW
3.05 B KRW
5.75 B KRW

NanoEnTek Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 12:40 PM
 
REVENUE (M KRW)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M KRW)
NET INCOME (M KRW)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales NanoEnTek generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue NanoEnTek retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare NanoEnTek's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares NanoEnTek has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against NanoEnTek's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

NanoEnTek stock margins

The NanoEnTek margin analysis displays the gross margin, EBIT margin, as well as the profit margin of NanoEnTek. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for NanoEnTek.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
39.3 %
-18.23 %
-59.64 %
Jan 1, 2006
46.21 %
-47.12 %
-176.03 %
Jan 1, 2007
35.94 %
-46.48 %
-158.33 %
Jan 1, 2008
33.89 %
-24.92 %
-84.95 %
Jan 1, 2009
37.08 %
13.43 %
107.59 %
Jan 1, 2010
18.29 %
-12.94 %
-43.5 %
Jan 1, 2011
5.65 %
-60.69 %
-92.77 %
Jan 1, 2012
8.54 %
-39.67 %
-43.79 %
Jan 1, 2013
27.13 %
-2.48 %
-6.48 %
Jan 1, 2014
28 %
-13.29 %
-12.64 %
Jan 1, 2015
24.49 %
-29.03 %
-29.32 %
Jan 1, 2016
21.57 %
-43.61 %
-66.64 %
Jan 1, 2017
43.62 %
7.03 %
-8.7 %
Jan 1, 2018
43.41 %
10.95 %
12.82 %
Jan 1, 2019
48.4 %
11.62 %
21.9 %

NanoEnTek Stock Revenue, EBIT, Earnings per Share

The NanoEnTek earnings per share therefore indicates how much revenue NanoEnTek has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
2,664.11 KRW
-485.56 KRW
-1,589 KRW
Jan 1, 2006
915.17 KRW
-431.25 KRW
-1,611 KRW
Jan 1, 2007
653.94 KRW
-303.94 KRW
-1,035.35 KRW
Jan 1, 2008
379.06 KRW
-94.47 KRW
-322 KRW
Jan 1, 2009
737.22 KRW
99 KRW
793.17 KRW
Jan 1, 2010
841.94 KRW
-108.94 KRW
-366.22 KRW
Jan 1, 2011
692.32 KRW
-420.16 KRW
-642.26 KRW
Jan 1, 2012
707.11 KRW
-280.47 KRW
-309.63 KRW
Jan 1, 2013
954.2 KRW
-23.65 KRW
-61.85 KRW
Jan 1, 2014
886.32 KRW
-117.82 KRW
-112 KRW
Jan 1, 2015
1,079.96 KRW
-313.52 KRW
-316.61 KRW
Jan 1, 2016
925.25 KRW
-403.54 KRW
-616.63 KRW
Jan 1, 2017
992.08 KRW
69.71 KRW
-86.33 KRW
Jan 1, 2018
992.19 KRW
108.69 KRW
127.23 KRW
Jan 1, 2019
1,009.85 KRW
117.35 KRW
221.15 KRW

NanoEnTek business model & stock analysis

NanoenTek, Inc. engages in the manufacture and sale of diagnostics and analytical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-08-16. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Company’s products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. The company also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The firm distributes its products within domestic market and to overseas markets.

NanoEnTek Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

NanoEnTek historical P/E ratio, EBIT multiple, and P/S ratio

NanoEnTek annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

NanoEnTek shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
9 M base_Shares
Jan 1, 2006
12 M base_Shares
Jan 1, 2007
17 M base_Shares
Jan 1, 2008
17 M base_Shares
Jan 1, 2009
18 M base_Shares
Jan 1, 2010
18 M base_Shares
Jan 1, 2011
19 M base_Shares
Jan 1, 2012
19 M base_Shares
Jan 1, 2013
20 M base_Shares
Jan 1, 2014
22 M base_Shares
Jan 1, 2015
23 M base_Shares
Jan 1, 2016
24 M base_Shares
Jan 1, 2017
24 M base_Shares
Jan 1, 2018
26 M base_Shares
Jan 1, 2019
26 M base_Shares

NanoEnTek Dividend History

2 years of dividend payments

YearAnnual DividendYoY ChangePayments
200350KRW 50.0%
2001100KRW
Price targets and forecasts for NanoEnTek are not yet available.

NanoEnTek shareholder structure

% Name
21.36279%
Aplus Asset Advisor Co. Ltd
Aplus Asset Advisor Co. Ltd
17.83507%
A Plus Life Co., Ltd.
A Plus Life Co., Ltd.
3.72421%
AI Healthcare Co., Ltd.
AI Healthcare Co., Ltd.
0.99795%
Jeong (Chan Il)
Jeong (Chan Il)
0.10382%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.02378%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.0015%
Hwang (Seung Mok)
Hwang (Seung Mok)
0.00015%
DFA Australia Ltd.
DFA Australia Ltd.
%
Kiwoom Asset Management Co., Ltd.
Kiwoom Asset Management Co., Ltd.

NanoEnTek Executives and Management Board

CJ

Chan Yil Jung

(47)

Chief Executive Officer, Director · since 2006

HC

Han Sang Cho

(45)

Managing Director · since 2006

HA

Hui Don Ahn

(45)

Assistant Managing Director

JB

Jae Geun Bae

(67)

Internal Auditor

SB

Seong Yeol Bae

(48)

Internal Auditor

NanoEnTek Supply Chain

Frequently asked questions about NanoEnTek

All fundamentals and in-depth analysis of NanoEnTek

Our stock analysis for NanoEnTek Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoEnTek Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.